The antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir, affect inflammation and insulin sensitivity in human coronary endothelial cells through different pathways
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137247
下载链接
链接失效反馈官方服务：
资源简介：
The antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir, affect inflammation and insulin sensitivity in human coronary endothelial cells through different pathways. Human coronary endothelial cells treated with the antiretroviral drugs dolutegravir, maraviroc and ritonavir-boosted atazanavir.
创建时间：
2020-02-05
